Atossa Therapeutics, Inc. (ATOS) vs LeonaBio, Inc. (LONA)
A side-by-side comparison of Atossa Therapeutics, Inc. and LeonaBio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATOS
Atossa Therapeutics, Inc.
$2.53HealthcareDelayed quote: Oct 6, 2026, 11:08 AM EDT
LONA
LeonaBio, Inc.
$5.58HealthcareDelayed quote: Oct 6, 2026, 11:09 AM EDT
Total return — ATOS vs LONA
growth of $100 · dividends reinvested · last 6yATOS -92.7% (-35.4%/yr)LONA -96.7% (-43.5%/yr)ATOS compounded faster over this window
ATOS LONA
ATOS vs LONA: by the numbers
- •ATOS is the larger company ($25M vs $22M market cap).
Metrics side by side
Valuation
| Metric | ATOS | LONA |
|---|---|---|
| P/B ratio | 0.94 | 0.66 |
Profitability
| Metric | ATOS | LONA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -140.55% | -421.06% |
| ROIC | -146.30% | -248.21% |
Growth (annualized)
| Metric | ATOS | LONA |
|---|---|---|
| Total return CAGR (5Y) | -44.50% | -43.13% |
Frequently asked
- How have ATOS and LONA total returns compared?
- Over the past 5 years, ATOS delivered -44.50% and LONA delivered -43.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.